Product Information
LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB is a generic product labeled by Cipla USA Inc., priced at $0.0366 per EA under NDC 69097096912. Its NADAC has been published 325 times since Jun 3, 2020.
FDA first approved this application on May 23, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB
Lisinopril and Hydrochlorothiazide TabletsStrength
12.5; 20 mg/1; mg/1
Manufacturer
Cipla USA Inc.NDC
69097096912
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; LISINOPRILApproval Type
Generic (ANDA)
FDA Application
ANDA204058FDA Approved
5/23/2017
TE Code
AB
On Market Since
12/26/2019
Pharmacological Classes
Price Statistics
The NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has been published 325 times since Jun 3, 2020, and over the history we have for it it has declined 24.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0366 per EA |
|---|---|
| All-time high | $0.0587 (Oct 13, 2021) |
| All-time low | $0.0311 (Nov 20, 2024) |
| 52-week high | $0.0413 |
| 52-week low | $0.0366 |
| Median price | $0.0467 |
| Average price | $0.0459 |
| Largest weekly change | -29.0% (Nov 20, 2024) |
| Weeks tracked | 325 |
| Tracking since | Jun 3, 2020 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB, manufactured by Cipla USA Inc., is $0.0366 per EA (NDC 69097096912), effective Aug 19, 2026.
How has the price of LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has declined 24.9%. It has been tracked across 325 weekly CMS publications since Jun 3, 2020.
What are the highest and lowest recorded NADAC prices for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
Since Jun 3, 2020, the NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has ranged from a low of $0.0311 (Nov 20, 2024) to a high of $0.0587 (Oct 13, 2021), with a median of $0.0467 per EA.
Are there cheaper alternatives to LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB (NDC 69097096912) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.